Podcast: Patients, Not Profits, Should Drive Drug Discovery | Vibe Bio, Alok Tayi

In this episode of Empire, Santi is joined by Alok Tayi, scientist and founder of Vibe Bio. Alok started Vibe Bio because the biggest obstacle in treating patients with overlooked diseases isn’t finding potential treatments — it’s funding them.

Vibe Bio is leveraging crypto’s economic and coordination tools to fund the research and development that the legacy biotech industry ignores. Don’t miss this fascinating conversation!

We discuss:

• Vibe Bio’s origin story and how it works
• Big pharma’s dilemma
• Why these diseases don’t receive funding today
• Project prioritization
• Crypto’s unique advantages
• The $VIBE token
• How to grow and leverage Vibe’s community
• Diseases don’t care about interest rates
• Biggest challenges

Check out what they had to say in the video below.👇

About the show

“Empire” is a twice-a-week show where we share the real crypto stories that aren’t heard elsewhere. On Mondays, Jason Yanowitz and Santiago Santos interview crypto industry movers and shakers to talk about their struggles, bold moves and tough decisions. Finish off the week with Friday’s weekly roundup episode that covers the top news and narratives of the week.

For any NPR or Guy Raz fans out there, you can think of “Empire” as a “How I Built This” for Web3.

Subscribe to “Empire” today on Apple or Spotify. Watch episodes on YouTube.

---

Start your day with top crypto insights from David Canellis and Katherine Ross. Subscribe to the Empire newsletter.

Explore the growing intersection between crypto, macroeconomics, policy and finance with Ben Strack, Casey Wagner and Felix Jauvin. Subscribe to the Forward Guidance newsletter.

Get alpha directly in your inbox with the 0xResearch newsletter — market highlights, charts, degen trade ideas, governance updates, and more.

The Lightspeed newsletter is all things Solana, in your inbox, every day. Subscribe to daily Solana news from Jack Kubinec and Jeff Albus.